FraxidinCAS# 525-21-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 525-21-3 | SDF | Download SDF |
PubChem ID | 3083616 | Appearance | Powder |
Formula | C11H10O5 | M.Wt | 222.2 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 8-hydroxy-6,7-dimethoxychromen-2-one | ||
SMILES | COC1=C(C(=C2C(=C1)C=CC(=O)O2)O)OC | ||
Standard InChIKey | QNFBKOHHLAWWTC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H10O5/c1-14-7-5-6-3-4-8(12)16-10(6)9(13)11(7)15-2/h3-5,13H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | In vitro inducible nitric oxide synthesis inhibitory active constituents from Fraxinus rhynchophylla.[Pubmed: 10575381 ]Planta Med. 1999 Oct;65(7):656-8.
|
Fraxidin Dilution Calculator
Fraxidin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.5005 mL | 22.5023 mL | 45.0045 mL | 90.009 mL | 112.5113 mL |
5 mM | 0.9001 mL | 4.5005 mL | 9.0009 mL | 18.0018 mL | 22.5023 mL |
10 mM | 0.45 mL | 2.2502 mL | 4.5005 mL | 9.0009 mL | 11.2511 mL |
50 mM | 0.09 mL | 0.45 mL | 0.9001 mL | 1.8002 mL | 2.2502 mL |
100 mM | 0.045 mL | 0.225 mL | 0.45 mL | 0.9001 mL | 1.1251 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Dihydrokainic acid
Catalog No.:BCC6556
CAS No.:52497-36-6
- PSB 36
Catalog No.:BCC7240
CAS No.:524944-72-7
- Peonidin-3-O-arabinoside chloride
Catalog No.:BCN3029
CAS No.:524943-91-7
- D-Tryptophanol
Catalog No.:BCC2699
CAS No.:52485-52-6
- 5-(Z-heptadec-8-enyl) resorcinol
Catalog No.:BCN5674
CAS No.:52483-19-9
- Isokurarinone
Catalog No.:BCN2890
CAS No.:52483-02-0
- Vandetanib hydrochloride
Catalog No.:BCC2028
CAS No.:524722-52-9
- ERB 041
Catalog No.:BCC7903
CAS No.:524684-52-4
- 1-Cinnamoylpyrrolidine
Catalog No.:BCN4086
CAS No.:52438-21-8
- Isobutylshikonin
Catalog No.:BCN3005
CAS No.:52438-12-7
- Oxeladin Citrate
Catalog No.:BCC3831
CAS No.:52432-72-1
- Cochlearine
Catalog No.:BCN1929
CAS No.:52418-07-2
- Harmalol
Catalog No.:BCC8183
CAS No.:525-57-5
- Kinetin
Catalog No.:BCC1679
CAS No.:525-79-1
- Flavone
Catalog No.:BCN8477
CAS No.:525-82-6
- Quercetin 3-O-robinobioside
Catalog No.:BCN5676
CAS No.:52525-35-6
- 5,7-Dihydroxychromone 7-rutinoside
Catalog No.:BCN3333
CAS No.:52538-46-2
- Pranoprofen
Catalog No.:BCC4828
CAS No.:52549-17-4
- Ingenol 3-palmitate
Catalog No.:BCN7686
CAS No.:52557-26-3
- bPiDDB
Catalog No.:BCC7606
CAS No.:525596-66-1
- Glycozolinine
Catalog No.:BCN5677
CAS No.:5257-08-9
- Acm-thiopropionic acid
Catalog No.:BCC2838
CAS No.:52574-08-0
- Phellamurin
Catalog No.:BCN5678
CAS No.:52589-11-4
- Neophellamuretin
Catalog No.:BCN7888
CAS No.:52589-20-5
In vitro inducible nitric oxide synthesis inhibitory active constituents from Fraxinus rhynchophylla.[Pubmed:10575381]
Planta Med. 1999 Oct;65(7):656-8.
Bioassay-guided fractionation of an H2O extract of the barks of Fraxinus rhynchophylla has furnished two inducible nitric oxide synthase (iNOS) inhibitory compounds, ferulaldehyde (1) and scopoletin (3) together with a coumarin, Fraxidin (2). Compounds 1 and 3 showed inhibition of nitric oxide (NO) synthesis in a dose-dependent manner by murine macrophage-like RAW 264.7 cells stimulated with interferon-gamma (IFN-gamma) plus lipopolysaccharide (LPS). The inhibition of NO synthesis of 1 was reflected in the decreased amount of iNOS protein, as determined by Western blotting.